盐酸右美托咪定在颅内动脉瘤介入治疗中的麻醉效果

doi:10.3760/cma.j.issn.1007-1245.2022.06.008

国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (6): 765-768.DOI: 10.3760/cma.j.issn.1007-1245.2022.06.008

盐酸右美托咪定在颅内动脉瘤介入治疗中的麻醉效果

赵贞贞

郑州市心血管病医院郑州市第七人民医院麻醉科，郑州　450000

收稿日期:2021-11-03 出版日期:2022-03-15 发布日期:2022-04-15
通讯作者: 赵贞贞，Email: huanggyonglu@163.com
基金资助:
河南省医学科技攻关项目（201801121）

Anesthetic effect of dexmedetomidine hydrochloride in interventional treatment for intracranial aneurysms

Zhao Zhenzhen

Department of Anesthesiology, Zhengzhou Cardiovascular Hospital, Zhengzhou Seventh People's Hospital, Zhengzhou 450000, China

Received:2021-11-03 Online:2022-03-15 Published:2022-04-15
Contact: Zhao Zhenzhen，Email: huanggyonglu@163.com
Supported by:
Medical Science and Technology Project of Henan Province (201801121)

摘要/Abstract

摘要： 目的　探讨盐酸右美托咪定在颅内动脉瘤介入治疗中的麻醉效果。方法　回顾性分析，选取郑州市心血管病医院2020年1月至2021年8月收治的60例接受介入手术治疗的颅内动脉瘤患者作为研究对象，根据麻醉方案不同将患者分为对照组（30例，接受常规全身麻醉）与研究组（30例，接受右美托咪定全身麻醉）。对照组男17例、女13例，年龄（57.21±6.33）岁；研究组男18例、女12例，年龄（57.38±6.42）岁。对比两组的开眼时间、拔管时间、恢复室停留时间及苏醒时脑电双频指数（BIS），麻醉诱导前（T₀）及维持后15 min（T₁）、30 min（T₂）时的收缩压（SBP）、心率（HR）、平均动脉压（MAP）及麻醉并发症。计量资料组间比较采用独立样本t检验，组内采用配对t检验，计数资料采用χ²检验。结果　T₀时，两组颅内动脉瘤患者HR、SBP、MAP比较，差异均无统计学意义（均P>0.05）；T₁时，研究组MAP为（99.35±10.62）mmHg（1 mmHg=0.133 kPa），高于对照组（87.45±4.80）mmHg，差异有统计学意义（P<0.05），两组颅内动脉瘤患者HR、SBP比较，差异均无统计学意义（均P>0.05）；T₂时，研究组HR、SBP、MAP［（69.52±6.27）次/min、（146.33±5.67）mmHg、（98.12±7.69）mmHg］均高于对照组［（66.43±5.29）次/min、（143.77±3.57）mmHg、（89.38±4.62）mmHg］，差异均有统计学意义（均P<0.05）。研究组开眼时间、恢复室停留时间、拔管时间分别为（16.37±2.03）min、（35.20±10.07）min、（12.28±2.38）min，均短于对照组（24.28±4.95）min、（54.43±12.86）min、（24.20±6.71）min，差异均有统计学意义（均P<0.05）；两组颅内动脉瘤患者苏醒时BIS比较，差异无统计学意义（P>0.05）。两组颅内动脉瘤患者麻醉并发症发生率比较，差异无统计学意义（χ²=0.577，P=0.448）。结论　盐酸右美托咪定在颅内动脉瘤介入手术中的麻醉效果良好确切，患者术中生命体征平稳，术后苏醒质量较高且并发症发生率低。

关键词: , 颅内动脉瘤, 介入栓塞术, 盐酸右美托咪定, 苏醒质量, 生命体征

Abstract:

Objective　To investigate the anesthetic effect of dexmedetomidine hydrochloride in interventional treatment for intracranial aneurysms. Methods　This is a retrospective analysis. A total of 60 patients with intracranial aneurysms who received interventional treatment in Zhengzhou Cardiovascular Hospital from January 2020 to August 2021 were selected as the research objects. According to the different anesthesia schemes, the patients were divided into a control group (30 cases, receiving conventional general anesthesia) and a study group (30 cases, receiving general anesthesia with dexmedetomidine). In the control group, 17 males and 13 females were (57.21±6.33) years old; in the study group, 18 males and 12 females were (57.38±6.42) years old. The time of eye opening, extubation time, stay time in recovery room, bispectral index (BIS) when recovery, and anesthetic complications were compared between the two groups, as well as systolic blood pressure (SBP), heart rate (HR), and mean arterial pressure (MAP) before induction of anesthesia (T₀) and 15 min (T₁) and 30 min (T₂) after maintenance. Independent sample t test was used for inter-group comparison of the measurement data, paired t test was used for intra-group comparison of the measurement data, and χ² test was used for the count data. Results　At T₀, there were no statistically significant differences in the HR, SBP, and MAP between the two groups (all P>0.05). At T₁, the MAP of the study group was (99.35±10.62) mmHg (1 mmHg=0.133 kPa), which was higher than that of the control group [(87.45±4.80) mmHg], with a statistically significant difference (P<0.05); there were no statistically significant differences in the HR and SBP (both P>0.05). At T₂, the HR, SBP, and MAP of the study group [(69.52±6.27) beats /min, (146.33±5.67) mmHg, and (98.12±7.69) mmHg] were higher than those of the control group [(66.43±5.29) beats /min, (143.77±3.57) mmHg, and (89.38±4.62) mmHg], with statistically significant differences (all P<0.05). The time of eye opening, stay time in recovery room, and extubation time in the study group were (16.37±2.03) min, (35.20±10.07) min, and (12.28±2.38) min, respectively, which were shorter than those in the control group [(24.28±4.95) min, (54.43±12.86) min, and (24.20±6.71) min], with statistically significant differences (all P<0.05). There was no statistically significant difference in the BIS between the two groups when recovery (P>0.05). There was no statistically significant difference in the incidence of anesthetic complications between the two groups (χ²=0.577, P=0.448). Conclusion　Dexmedetomidine hydrochloride has a good anesthetic effect in interventional surgery for intracranial aneurysms, with stable patients' vital signs during the operation, high quality of postoperative recovery, and a low incidence of complications.

Key words: Intracranial aneurysms, Interventional embolization, Dexmedetomidine hydrochloride, Recovery quality, Vital signs

赵贞贞.

盐酸右美托咪定在颅内动脉瘤介入治疗中的麻醉效果 [J]. 国际医药卫生导报, 2022, 28(6): 765-768.

Zhao Zhenzhen. Anesthetic effect of dexmedetomidine hydrochloride in interventional treatment for intracranial aneurysms [J]. International Medicine and Health Guidance News, 2022, 28(6): 765-768.

参考文献

[1] 牟磊,秦军,雷军荣,等. LVIS Jr支架在治疗前交通宽颈动脉瘤中的疗效分析[J]. 中华显微外科杂志,2019,42(5):504-506. DOI:10.3760/cma.j.issn.1001-2036.2019. 05.023.

[2] 王芳,高昌健,郑元元. 预防性使用拉贝洛尔联合吸入七氟醚维持麻醉对伴高血压颅内动脉瘤介入术患者血压、脑血流及颅内压的影响[J]. 实用癌症杂志,2019,34(9):1536-1538. DOI:10.3969/j.issn.1001-5930.2019.09.042.

[3] 王美芳. 右美托咪定对颅内动脉瘤手术患者血流动力学的影响及对脑保护的作用探讨[J]. 中国社区医师,2020,36(1):26-27. DOI:10.3969/j.issn.1007-614x.2020.01.013.

[4] Rebecca B, William S, Neifert SN, et al. The use of the American Society of Anesthesiologists (ASA) classification system in evaluating outcomes and charges following deformity spine procedures[J]. Neurosurgery,2020,67:253.

[5] 中华医学会神经外科学分会神经介入学组. 颅内动脉瘤血管内介入治疗中国专家共识(2013)[J]. 中国脑血管病杂志,2013,10(11):606-616.

[6] 陈振,张松,晋亚洲,等. 支架辅助弹簧圈栓塞与血流导向装置治疗大型和巨大型颅内动脉瘤的疗效对比分析[J]. 中华神经外科杂志,2020,36(12):1211-1216. DOI:10.3760/cma.j.cn112050-20200407-00212.

[7] 吴姗姗,李锦汶,梅凤美,等. 控制性降压对颅内动脉瘤夹闭术中脑氧饱和度和术后神经认知功能的影响[J]. 临床麻醉学杂志,2019,35(10):941-944. DOI:10.12089/jca.2019. 10.001.

[8] 陈振,张松,晋亚洲,等. 支架辅助弹簧圈栓塞与单纯弹簧圈栓塞治疗颅内破裂动脉瘤疗效的对比分析[J]. 中华神经外科杂志,2020,36(1):38-43. DOI:10.3760/cma.j.issn.1001-2346.2020.01.010.

[9] 谢奇朋,崔常雷,贺超,等. 比较罗哌卡因和利多卡因表面麻醉在颅内动脉瘤夹闭术中对气管插管及拔管时应激反应的影响[J]. 中国实验诊断学,2019,23(2):284-286. DOI:10.3969/j.issn.1007-4287.2019.02.035.

[10] 李建军,徐文中,郭志波,等. 右美托咪定辅助血管内介入栓塞术对颅内动脉瘤患者血清MMP-9NSE及S100β水平的影响[J]. 中国实用神经疾病杂志,2019,22(19):2160-2166. DOI:10.12083/SYSJ.2019.19.357.

[11] 张君婷,张宏伟,王忠祥,等. 利多卡因预处理联合右美托咪定对颅内动脉瘤夹闭术患者脑损伤的保护作用[J]. 中外女性健康研究,2019,27(20):47-48.

[12] 李敏,刘志贵,石泉,等. 右美托咪定滴鼻对颅内动脉瘤介入治疗全麻拔管期血流动力学的影响[J]. 中国临床神经外科杂志,2019,24(2):87-89,92. DOI:10.13798/j.issn.1009- 153X.2019.02.008.

[13] 韩明杰,张凌宇. 右美托咪定用于肝脏部分切除术患者麻醉的临床效果[J]. 国际医药卫生导报,2021,27(3):405-410. DOI:10.3760/cma.j.issn.1007-1245.2021.03.026.

盐酸右美托咪定在颅内动脉瘤介入治疗中的麻醉效果

Anesthetic effect of dexmedetomidine hydrochloride in interventional treatment for intracranial aneurysms

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

[1]	赵洋, 周洁, 耿朝辉. 高血压患者认知衰弱评估及影响因素的研究进展[J]. 国际医药卫生导报, 2022, 28(6): 748-752.
[2]	刘斯平, 毛海燕. MSCT多期增强在结直肠癌术前TN分期中的价值分析及与病理分期对照研究[J]. 国际医药卫生导报, 2022, 28(4): 464-467.
[3]	刘慧轩, 何雅军. 血清胸苷激酶1对甲状腺癌诊断价值的meta分析[J]. 国际医药卫生导报, 2022, 28(3): 357-360.